fertilityPATH
ClinicsDoctorsTreatmentsResourcesWho we are
Ask PATH
← ClinicsAberdeen Fertility Centre
Average · HFEA Licensed

Aberdeen Fertility Centre

Aberdeen, United KingdomHFEA: Average
Live birth rate
27%
-2pp vs UK avg
Cycles 2016–18
1,247
Low volume
Blastocyst rate
17%
stronger lab when higher
Multiple birth
1%
lower is safer
Starting from
price not listed

Should I shortlist this clinic?

Average outcomes — strongest for ages 38-39.

Based on age-adjusted HFEA live-birth data (2016–18) vs the UK national average.

Good fit if
you're in the 38-39 age band — their strongest results
you're considering IUI, their best-performing treatment
Look closer if
outcomes for the Under 35 age band are below the national average
it's a lower-volume clinic — fewer cycles behind the figures
Questions to ask before booking
·What's included in the quoted price, and what add-on costs are typical?
·What were your live-birth rates for my age group in the latest HFEA data?
·How many cycles like mine do you carry out each year?
Ask PATH about this clinic

Your question about this clinic travels with you — after sign-up it's waiting as the start of your first PATH conversation.

About

Aberdeen Fertility Centre presents a mixed image based on the provided review, reflecting both strengths in staff demeanor and significant weaknesses in operational efficiency and patient support. The primary positive aspect highlighted is the presence of 'incredibly friendly,' 'lovely compassionate staff,' suggesting a core team capable of delivering empathetic and patient-centered care. This aligns with the emotional sensitivity required in fertility treatment contexts, where patients often face high stress and vulnerability. However, these positive interpersonal interactions are overshadowed by severe systemic issues that profoundly impacted the reviewer's experience. The clinic's most glaring failure, according to this review, is its communication infrastructure and administrative coordination. The patient reported a three-year delay between initiating care at age 39 and receiving their first IUI treatment at age 42, despite being a paying client. While the review acknowledges the disruptive context of the COVID-19 pandemic, the patient explicitly deemed the delay 'inexcusable' given the time-sensitive nature of fertility treatments, particularly for individuals of advanced maternal age. This highlights potential deficiencies in case management prioritization, appointment scheduling efficiency, and crisis contingency planning. The delay directly impacted the patient's treatment window—fertility success rates decline significantly between ages 39 and 42, making timely intervention critical. Financial considerations emerge as another pain point, with the reviewer emphasizing having 'paid a lot of money' for what they characterize as 'shoddily' delivered services. This critique suggests a perceived misalignment between service costs and care quality, potentially indicating inadequate transparency in financial communication, disproportionate fees relative to service delivery speed, or insufficient value demonstration through ancillary support services. The financial dissatisfaction compounds the emotional toll of the prolonged treatment timeline. Staff competence appears inconsistent according to the review. While some team members demonstrated appropriate compassion, others exhibited 'compassion fatigue' or were perceived as being 'in the wrong job.' This dichotomy raises concerns about staff training adequacy, workload management, and emotional support systems for clinicians working in this high-stress specialty. Such inconsistencies could create unpredictable patient experiences depending on which staff members handle key interactions. The review implicitly questions the clinic's range of available treatments, describing it as 'disgusting' alongside criticism of support levels. Though not explicitly detailing treatment limitations, this suggests the patient perceived insufficient options tailored to their clinical needs, potentially reflecting outdated protocols, lack of personalized treatment pathways, or inadequate counseling about available alternatives. For a 39-year-old patient, prompt access to more advanced treatments like IVF might have been clinically warranted rather than a multi-year wait for IUI, implying possible gatekeeping or protocol rigidity. Support services—including psychological counseling, patient navigation, or educational resources—appear lacking given the reviewer's emphasis on 'level of support' as a failure point. Effective fertility care requires robust support systems to help patients navigate complex emotional and logistical challenges, and this deficiency likely exacerbated the negative experience. In summary, Aberdeen Fertility Centre demonstrates capacity for compassionate individual care but suffers from critical operational shortcomings in care coordination, timeline management, staff consistency, and support service provision. These deficiencies disproportionately impact older patients facing time-sensitive fertility decline. The clinic's ability to deliver timely, organized, and transparent care—particularly during external crises like pandemics—appears to need significant improvement to match the baseline compassion displayed by portions of its staff.

Treatments offered
Lab quality signals
17%
Blastocyst rate
Higher = stronger lab
64%
Elective single ET
eSET = ethical practice
1%
Multiple birth rate
Lower = safer outcomes

Questions people ask about Aberdeen Fertility Centre

Written in PATH's voice from this clinic's published HFEA data — reviewed before publishing, never generated live.

Is Aberdeen Fertility Centre a sensible choice if I'm under 35?

Fair thing to check before choosing. Aberdeen Fertility Centre's best relative results are actually in the 38-39 band, at 30% against a 24% national average, while the under-35 band it reports comes in at 24% versus a national 38% — below what you'd typically expect for that age group. The 35-37 band sits lowest of all here, at 15% against 32% nationally. The clinic's overall rate is 27%, close to the 29% national average. Aberdeen Fertility Centre is low volume too, so its year-to-year numbers can move around more than a larger clinic's.

What's the basis for the success rate Aberdeen Fertility Centre quotes?

It's a live-birth rate per embryo transferred, sourced from HFEA-verified regulated data covering 2016 to 2018 — externally checked rather than self-reported. Before comparing Aberdeen Fertility Centre against other clinics, it's worth confirming two things: whether a quoted rate is per embryo transferred or per cycle started, since these aren't the same measure, and which years the figure actually covers. Clinics can report on slightly different windows, so a same-looking number doesn't always mean a like-for-like comparison.

What should I ask Aberdeen Fertility Centre at my first appointment?

A handful of direct questions can tell you a lot. Worth putting to Aberdeen Fertility Centre: - what's included in the quoted price, and which add-on costs commonly apply - what their live-birth rates were for your age group in the latest HFEA data - how many cycles like yours they carry out each year, given the lower caseload here. None of this is confrontational to ask, and a good consultant will welcome the chance to answer clearly.

These answers use published data only — PATH personalizes once it knows your age, your numbers, and your story.

Get in Touch

Ready to start your journey? Contact the clinic directly.

Ask PATH if this clinic fits youRequest Consultation

Opens in the app — you'll create a free account first.

Compare Clinics

fertilityPATH earns no referral fees. We recommend clinics based on data, not commercial relationships.

Quick intel
Best age band38-39
Total cycles1,247
Blastocyst rate17%
Elective single ET64%
Multiple birth rate1%
Bias firewall
This clinic has not paid for placement. Data from HFEA + patient reviews only.
© 2026 fertilityPATH. All rights reserved.Privacy·Terms·Cookies·Subprocessors·